http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2455982-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5f554278206e52fc0b4acdf30628464
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
filingDate 2010-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_175f64d45b89d2c83c03545548deeff9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df311fc944ec91193bc16b6d92aca7de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e29f9b9253547c737b02c638dd37c182
publicationDate 2012-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2455982-C1
titleOfInvention Method of treating patients with mycosis fungoides
abstract FIELD: medicine. n SUBSTANCE: invention relates to medicine, namely to dermatology and can be used for treatment of patients with mycosis funcoides. For this purpose therapy with PUVA-baths with solution of photosensitiser is performed 3 times a week. Additionally with PUVA-baths at the background of symptomatic therapy: antihistamine preparations, external ointment therapy administered are corticosteroid hormone prednisolone perorally in adaptive dose 0.3 mg/kg/day during 15-20 days and 10 intramuscular injections of immunomodulator - interal in dose 1 mln IU every second day. PUVA baths are carried out with total course of 10 sessions. n EFFECT: method makes it possible to achieve clinical improvement in patients with application of smaller cumulative course doses of UVA, which leads to reduction of risk of side effects and reduction of hospital treatment duration. n 2 ex, 3 tbl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2699800-C2
priorityDate 2010-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2182481-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2234921-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10376
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3440
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546216
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4114
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2355
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222786
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3080647
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481803
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68079
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP05004
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527393
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01563
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396398
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01573
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408223641
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10376
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506586
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID515951
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID2725057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449064297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID298213
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID2725057

Total number of triples: 51.